- AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection. Our flagship product, PREVYMIS, marketed by our partner MSD, treats CMV in a defined group of transplant recipients. Our pivotal phase 3 candidate Pritelivir aims to address recurrent and resistant HSV infections in a broad population of patients with weakened immune systems. For immunocompromised...
IT Systems and Solution Architect* – Comm. and Finance
AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection. Our flagship product, PREVYMIS, marketed by our partner MSD, treats CMV in a defined group of transplant recipients. Our pivotal phase 3 candidate Pritelivir aims to address recurrent and resistant HSV infections in a broad population of patients with weakened immune systems. For immunocompromised people, an otherwise manageable infection can mean life or death. AiCuris, with its expertise and growing pipeline, is committed to providing therapeutic solutions for them now and in the future. We believe in a culture of trust and transparency, where feedback is considered an opportunity to contribute to each other's personal and professional growth. We hire people who are collaborative, adaptable, communicate well, and love to learn. *AiCuris is an employer that supports equal opportunities, diversity and inclusion. We welcome applications from people regardless of their national origin, skin color, religion, gender, age, marital status, disability, sexual orientation, gender identity or other legally protected
Jetzt ansehen
* Partnerlink – Anzeige bei StepStone
Alternative Stellenangebote von AiCuris Anti-infective Cures AG
Weitere "Architekt" Jobs in Wuppertal
2 aktuelle Stellenangebote - IT-Architektin / IT-Architekt (m/w/d) Elektronische Patientenakte (ePA) / Telematikinfrastruktur Wir sind über 15.000 Kolleginnen und Kollegen. Jeder von uns hat seinen individuellen Grund, bei der BARMER zu arbeiten – und jeder Grund ist uns wichtig. Aber eines haben wir alle gemeinsam: Wer hier arbeitet, setzt sich täglich für die Gesundheit von Millionen von Menschen ein: Weil wir helfen, gesünder zu leben, bei Krankheit die...
- AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection. Our flagship product, PREVYMIS, marketed by our partner MSD, treats CMV in a defined group of transplant recipients. Our pivotal phase 3 candidate Pritelivir aims to address recurrent and resistant HSV infections in a broad population of patients with weakened immune systems. For immunocompromised...